1. All of the following are risk indicators for periodontitis EXCEPT _______________.
  1. PISA measures the articular and systemic disease activity of RA; DAS measures the inflamed surface area within a periodontal pocket.
  1. Studies show that patients with RA have an increased prevalence of periodontal disease versus those without RA or other forms of arthritis.
  1. Do bacteria play a role in both the etiology of RA and periodontitis?
  1. In patients with RA, periodontitis is at least _____-fold more prevalent than in the general population.
  1. RA subjects do not demonstrate higher levels of bleeding on probing (BOP).
  1. What medication has been shown as an adjunctive benefit the reduction of overall signs of periodontal inflammation in patients with periodontitis?
  1. Non-surgical periodontal therapy decreased all of the following common inflammatory factors in patients with RA and periodontitis, EXCEPT _______________.
  1. In one cohort study of RA patients, what percentage of those RA patients had periodontitis?
  1. Chronic corticosteroid stimulation has been an effective therapy for periodontitis and has been linked to a decreased susceptibility to periodontitis.
  1. All of the following are considered virulence factors that bacteria may possess EXCEPT _______________.
  1. P.g. can elicit the host to respond and attempt to clear the bacterial infection, which can result in _______________?
  1. The primary etiology of periodontitis is _______________.
  1. DMARDs and anti-TNF-α have consistent therapeutic results in both RA and periodontitis.
  1. Management and treatment of RA and periodontitis is interdisciplinary and should include a dental professional, such as the patient’s dentist or periodontist, and a medical professional, such as the patient’s rheumatologist or treating physician.